Exercise and a weight-loss drug for people with obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether combining a GLP-1 medication (a type of diabetes drug that also helps with weight loss) with an exercise program can improve physical function in people with obesity. If you are obese and have trouble with daily activities, this study may help you become more mobile and healthier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have obesity (body mass index, or BMI, of 30 or higher).
- You have some difficulty doing everyday physical tasks (like walking or getting up from a chair).
- Your primary doctor has given you permission to join.
- Your weight has been stable (not up or down more than 4%) in the last 2 months.
- You are not already exercising for 150 minutes or more per week.
- You do not have diabetes, serious heart or lung disease, or other major health issues listed in the full criteria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two different weight-loss medications (semaglutide and tirzepatide) taken alongside exercise to help people with obesity. It aims to see which approach works better for weight loss and overall health.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.
This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.
This study tests whether weight loss from a medication can improve how you feel, move, and how well your heart works. It's for people who have both obesity and heart failure with reduced pumping strength.
This trial tests whether adding resistance exercise and extra protein can help you keep your muscle while taking weight loss medications like semaglutide or tirzepatide. It is for people with a BMI of 27 or higher who are not already exercising regularly.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.